Kintara Urges Shareholder Votes for TuHURA Biosciences Merger

Kintara Therapeutics ( (KTRA) ) has issued an announcement.

Kintara Therapeutics, Inc. is urging its stockholders to vote on crucial proposals that will determine the company’s ability to complete a proposed merger with TuHURA Biosciences, Inc. The merger’s success hinges on meeting the voting threshold, and the future of Kintara could be at stake if the merger does not proceed. Investors and stockholders are advised to read the definitive proxy statement/prospectus and other relevant SEC filings thoroughly to make informed decisions on the merger. Kintara has emphasized the importance of stockholder participation and provides assistance for voting through Alliance Advisors.

For detailed information about KTRA stock, go to TipRanks’ Stock Analysis page.